Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Oliveira, Rodrigo A ^a   Lima, Cláudio G ^a   Mota, Rosa Ms ^a   Martins, Alice Mc ^a   Sanches, Talita R ^b   Seguro, Antônio C ^b,d   Andrade, Lúcia C ^b,d   Junior, Geraldo B Silva ^a,c   Libário, Alexandre B ^c   Daher, Elizabeth F ^a,d  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF FORTALEZA   (Brazil)

^d Fellow of the National Research Council   (Brazil)

Author keywords

American cutaneous leishmaniasis; Renal function; Treatment; Tubular defects

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CALCIUM; CREATININE; DESMOPRESSIN ACETATE; GLUCOSE; MAGNESIUM; MEGLUMINE ANTIMONATE; PHOSPHORUS; POTASSIUM; SODIUM;

ADULT; AMERICAN CUTANEOUS LEISHMANIASIS; ARTHRALGIA; ARTICLE; ASTHENIA; CALCIUM EXCRETION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DRUG FEVER; DRUG INDUCED HEADACHE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; KIDNEY ACIDIFYING CAPACITY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; MYALGIA; OSMOLALITY; PROSPECTIVE STUDY; SKIN LEISHMANIASIS; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION; URINE ACIDIFICATION; URINE PH;

ADULT; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862313865     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-44     Document Type: Article

References (24)

1. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Goto H, Lindoso JAL, Expert Rev Anti Infect Ther 2010 8 419 433 10.1586/eri.10.19 20377337
2. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Barral B, Pedral-Sampaio D, Grimaldi G, Momen H, Mc Mahon-Pratt D, Ribeiro de Jesus A, Almeida R, Badará R, Barral-Neto M, Carvalho EM, Johnson WD, Am J Trop Med Hyg 1991 44 536 546 2063957
3. Leishmaniasis and its etiologic agents in the New World: an overview. Grimaldi G, Mc-Mahon-Pratt D, Sun T, Prog Clin Parasitol 1991 2 73 118 1893120
4. Leishmaniose Tegumentar Americana. Gontijo B, Carvalho MLR, Rev Soc Bras Med Trop 2003 36 71 80 12715066
5. Leishmaniasis: current situation and new perspectives. Desjeux P, Comp Immunol Microbiol Infect Dis 2004 27 305 318 10.1016/j.cimid.2004.03.004 15225981
6. Leishmaniasis. Roberts LJ, Handeman E, Foote SJ, Br Med J 2000 321 801 804 10.1136/bmj.321.7264.801
7. Envolvimento da função renal em pacientes com leishmaniose visceral (calazar). Salgado-Filho N, Ferreira TM, Costa JM, Rev Soc Bras Med Trop 2003 36 217 221 10.1590/S0037-86822003000200004 12806457
8. A patient with visceral leishmaniasis and acute renal failure in necrotizing glomerulonephritis. Chaigne V, Knefati Y, Lafarge R, Bronner J, MC Gregor B, Fouque B, Sabatier JC, Nephrologie 2004 25 179 183 15455792
9. Important parasitic nephropathies: update from recent literature. Duvic C, Nedelec G, Debord T, Herody M, Didelot F, Nephrologie 1999 20 65 74 10227026
10. Risk factors for acute kidney injury in visceral leishmaniasis. Oliveira MJC, Silva Júnior GB, Abreu KLS, Rocha NA, Garcia AVV, Franco LFLG, Mota RMS, Libário AB, Daher EF, Am J Trop Med Hyg 2010 83 449 453 10.4269/ajtmh.2010.10-0313 20810802
11. Acute interstitial nephritis. Councilman WT, J Experiment Med 1988 3 393 420
12. Nephrotoxicyty to Glucantime in the treatment of leishmaniasis. Cucé LC, Belda J, Dias W, Rev Inst Med Trop S Paulo 1990 32 249 251 10.1590/S0036-46651990000400003 2101518
13. Interstitial nephritis in human kala-azar. Duarte MIS, Silva MRR, Gotto H, Nicodemo EL, Amato-Neto V, Trans R Soc Trop Med Hyg 1983 77 531 537 10.1016/0035-9203(83)90131-1 6636281
14. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. Lima Verde EM, Lima Verde FAA, Lima Verde FA, Silva Júnior GB, Daher EF, J Nephrol 2007 20 432 438
15. Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis. Rodrigues MLO, Costa RS, Souza CS, Fossi NT, Roselino AMF, Rev Inst Med Trop S Paulo 1999 41 33 37 10.1590/S0036-46651999000100007 10436668
16. Renal tubular dysfunction in patients with American cutaneous leishmaniasis. Oliveira RA, Diniz LFB, Teotonio LO, et al. Kidney Int 2011 80 1099 1106 10.1038/ki.2011.251 21814169
17. Systemic therapy of new world cutaneous leishmaniasis: a case report and review article. Abadir A, Patel A, Haider S, Can J Infect Dis Med Microbiol 2010 21 79 e83 21629609
18. Renal involvement in visceral leishmaniasis. Dutra M, Martinelli R, de Carvalho EM, et al. Am J Kidney Dis 1985 6 22 27 4025325
19. Renal function improvement with pentavalent antimonial agents in patients with visceral leishmaniasis. Daher EF, Rocha NA, Oliveira MJ, Franco LF, Oliveira JL, Silva Junior GB, Abreu KL, Henn GA, Martins AM, Libário AB, Am J Nephrol 2011 33 332 336 10.1159/000324914 21411988
20. Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. Elnojomi N, Musa AM, Younis BM, Elfaki M, EL-Hassan AM, Khalil E, Saudi J Kidney Dis Transpl 2010 21 872 875 20814123
21. Evaluation of renal function in leprosy: a study of 59 consecutive patients. Oliveira RA, Silva GB, Souza CJ, et al. Nephrol Dial Transplant 2008 23 256 262 17901068
22. Renal abnormalities in Leprosy. Kirsztajn GM, Nishida SK, Silva MS, Ajzen H, Pereira AB, Nephron 1993 65 381 384 10.1159/000187517 8289988
23. Avaliação da tolerncia e nefrotoxicidade do antimonial pentavalente administrado na dose de 40mg Sbv/kg/dia por 30 dias na forma cutnea-mucosa de leishmaniose. Sampaio RNR, Paula CDR, Sampaio JHD, Furtado RS, Leal PP, Rosa TT, Rodrigues MR, Veiga JPR, Rev Soc Bras Med Trop 1997 30 457 467 10.1590/S0037-86821997000600003 9463192
24. Veiga J.P.R. Khanan R. Rosa T.T. Junqueira L.F. Brant P.C. Raick A.N. Friedman H. Marsden P.D. Pentavalent antimonial nephrotoxicity in the rat Rev Inst Med Trop S Paulo 1990 32 304-309 10.1590/S0036-46651990000400012 2101525